This scholarship page was last updated on 31 March 2021. Some details may have changed since then. Please check the Department of Health and Human Services National Institutes of Health website or the Department of Health and Human Services National Institutes of Health page for current opportunities.

Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health

Tipo

Research/project funding

Posted on:

31 March 2021

Scadenza delle domande:

Expired

Reference Number

RFA-HG-21-006

The National Human Genome Research Institute intends to promote a new initiative by publishing a Request for Applications to solicit R01 applications for research in the area of Transformative Nucleic Acid Sequencing Technology Innovation and Early Development: The purpose of the RFA is to refocus and emphasize NHGRIs investment in nucleic acid sequencing technology on novel technology innovation and early development. This Notice is being provided to allow potential applicants sufficient time to develop effective collaborations and responsive projects. The FOA is expected to be published in the winter of 2021 with an expected application due date in the summer of 2021.
Categories: Health.

More Information

Visit Website